CANSINOBIO (06185) announced its financial results for the first three quarters of the year. For the nine months ended September 30, 2025, the company recorded revenue of RMB693 million, a year-on-year increase of 22.13%. Net profit attributable to shareholders reached RMB14.44 million, compared to a net loss of RMB222 million in the same period last year. Basic earnings per share stood at RMB0.06.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.